Introduction: Vascular resection remains a subject of debate in the management of
Pancreatic Ductal Adenocarcinoma (PDAC). These French recommendations were drafted …

Two areas that remain the focus of improvement in pancreatic cancer include high post-
operative morbidity and inability to uniformly translate surgical success into long-term …

Objective: The REDISCOVER consensus conference aimed at developing and validating
guidelines on the perioperative care of patients with borderline-resectable (BR-) and locally …

Background Open pancreatoduodenectomy with vein resection (OPD-VR) is now standard
of care in patients who responded to neoadjuvant therapies. Feasibility of robotic …

Background Resection of the porto-mesenterico-splenic confluence is at times necessary
during pancreatoduodenectomy with portal vein resection for pancreatic cancer. Although …

Background Venous resection of the superior mesenteric or portal vein is increasingly
performed in pancreatic cancer surgery, whereas results of studies on short-and long-term …

Vascular resections involving the superior mesenteric and portal veins (SMV-PV), celiac axis
(CA), superior mesenteric artery (SMA) and hepatic artery (HA) have multiplied in recent …

Simple Summary Aggressive arterial resection or total pancreatectomy in surgical treatment
for locally advanced pancreatic cancer (LAPC) has gradually been encouraged thanks to …

Pancreatic cancer (PDAC) is the fourth leading cause of cancer‐related mortality in the
Western world and, even in 2014, a therapeutic challenge. The only chance for long‐term …

Locally advanced pancreatic cancer (LAPC), which progresses locally and surrounds major
vessels, has historically been deemed unresectable. Surgery alone failed to provide curative …